New Delhi, Sep 26 (IANS) The 100 per cent tariff on pharmaceuticals, imposed by the US President Donald Trump, will cause harm only to the US, and not India, said experts on Friday.

The 100 per cent tariff by Trump, to be implemented from October 1, targets the import of branded and patented pharmaceutical drugs and does not apply to generic medicines.

“This would be very negative for the US, as medicines are very important for any economy. In India, our government has been striving to reduce the prices of medicine,” Akash Jindal, an economist, told IANS.

“This will not harm India, but only the US. The tariff imposed by America is very wrong,” added businessman Dr. Niranjan Hiranandani.

In a post on Truth Social, the US President stated, “Starting October 1, 2025, we will be imposing a

See Full Page